Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125356193 | 12535619 | 3 | F | 20160801 | 20160707 | 20160811 | EXP | PT-AUROBINDO-AUR-APL-2014-10265 | AUROBINDO | ALMEIDA JP, ET AL.. PROTON PUMP INHIBITORS DELAYED HYPERSENSITIVITY: CASE REPORT. REACTIONS WEEKLY. 2016;1608:238 | 39.00 | YR | F | Y | 0.00000 | 20160811 | OT | PT | PT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125356193 | 12535619 | 1 | PS | Esomeprazole | ESOMEPRAZOLE | 1 | Unknown | UNK | U | U | 205606 | ||||||||
| 125356193 | 12535619 | 2 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | UNK | Y | 0 | |||||||||
| 125356193 | 12535619 | 3 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Unknown | 4 MG, DAILY | Y | 0 | 4 | MG | |||||||
| 125356193 | 12535619 | 4 | SS | Pantoprazole | PANTOPRAZOLE SODIUM | 1 | Oral | UNK | U | 0 | |||||||||
| 125356193 | 12535619 | 5 | SS | ASPIRIN. | ASPIRIN | 1 | Intravenous (not otherwise specified) | UNK | U | 0 | |||||||||
| 125356193 | 12535619 | 6 | SS | IBUPROFEN. | IBUPROFEN | 1 | Oral | UNK | U | 0 | |||||||||
| 125356193 | 12535619 | 7 | SS | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Oral | UNK | U | 0 | |||||||||
| 125356193 | 12535619 | 8 | SS | PARACETAMOL | ACETAMINOPHEN | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 125356193 | 12535619 | 9 | SS | RABEPRAZOLE SODIUM. | RABEPRAZOLE SODIUM | 1 | Unknown | UNK | U | 0 | |||||||||
| 125356193 | 12535619 | 10 | C | DESLORATADINE. | DESLORATADINE | 1 | Unknown | 5 UNK, UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125356193 | 12535619 | 1 | Gastrooesophageal reflux disease |
| 125356193 | 12535619 | 2 | Gastrooesophageal reflux disease |
| 125356193 | 12535619 | 3 | Influenza like illness |
| 125356193 | 12535619 | 4 | Gastrooesophageal reflux disease |
| 125356193 | 12535619 | 5 | Product used for unknown indication |
| 125356193 | 12535619 | 6 | Product used for unknown indication |
| 125356193 | 12535619 | 7 | Gastrooesophageal reflux disease |
| 125356193 | 12535619 | 8 | Product used for unknown indication |
| 125356193 | 12535619 | 9 | Product used for unknown indication |
| 125356193 | 12535619 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125356193 | 12535619 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125356193 | 12535619 | Drug hypersensitivity | |
| 125356193 | 12535619 | Rash pruritic |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125356193 | 12535619 | 2 | 2008 | 0 | ||
| 125356193 | 12535619 | 3 | 2010 | 0 | ||
| 125356193 | 12535619 | 5 | 2007 | 0 | ||
| 125356193 | 12535619 | 6 | 2008 | 0 |